Alpha Tau Medical Ltd (DRTS) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alpha Tau Medical Ltd  (NASDAQ: DRTS)


Alpha Tau Medical Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alpha Tau Medical Ltd's ROI in the fourth quarter of 2025?
Alpha Tau Medical Ltd achieved a return on average invested assets (ROI) of 43.42 % in its fourth quarter of 2025, which is below Alpha Tau Medical Ltd's average return on investment, which stands at 43.96%.

ROI has improved compared to 32.04% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector 35 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 128.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM 18.54 % -1.05 % -8.85 % -19.62 % -24.18 %
Y / Y Net Income Change TTM 46.2 % -13.64 % -13.64 % -13.64 % -13.64 %
Investment (TTM) in Millions 98 95 104 95 69
Return On Investment (TTM) 43.42 % 32.04 % 33.48 % 35.01 % 35.21 %
DRTS's Overall Ranking # 128 # # # #
Seq. Investment Change TTM 7.87 % 4.51 % 4.57 % 0.55 % -9.96 %
Seq. Net Income Change TTM 46.2 % 0 % 0 % 0 % -13.64 %
Net Income (TTM) in Millions 43 29 29 29 29

DRTS Company Profile >> Back to DRTS Roi Comparisons >> See Annual DRTS Return On Investment



Return On Investment DRTS's Ranking
Within: No.
Industry # 8
Sector # 36
Overall # 128

Return On Investment Statistics
High Average Low
72.13 %
43.96 %
29.15 %
(Dec 31 2021)   (Dec 31 2022)







Financial Statements
Alpha Tau Medical Ltd's IV. Quarter Investments $ 98 Millions DRTS's Balance sheet
Alpha Tau Medical Ltd's IV. Quarter Income $ 43 Millions Quarterly DRTS's Income Statement
DRTS's Income by Division See DRTS's Income by Division


DRTS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 95 69 95 121 56
Y / Y Investment Growth 37.21 % -26.85 % -21.94 % 115.2 % -
Net Income in Millions 43 -32 29 34 27
Y / Y Net Income Growth - - -13.64 % 23.8 % -
Annual Return On Investment 44.8 % -45.79 % 30.76 % 27.8 % 48.32 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 44.8 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DRTS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DRTS's Competitors
Subscribers only: Roi for Alpha Tau Medical Ltd's Suppliers
Subscribers only: Return On Investment for DRTS's Customers

Other Ratios
DRTS's Roa DRTS's Inventory Turnover Ratio DRTS's Growth Rates DRTS's Dividend Statistics
DRTS's Profitability Ratios DRTS's Asset Turnover Ratio DRTS's Dividend Growth
DRTS's Roe DRTS's Valuation Ratios DRTS's Financial Strength Ratios DRTS's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Kyntra Bio Inc   118.89 %
Lifemd Inc   105.75 %
Biocryst Pharmaceuticals Inc   88.36 %
Advanced Biomed Inc.  84.64 %
Earth Science Tech Inc   78.43 %
Exelixis Inc   71.31 %
Entera Bio Ltd   63.91 %
Tg Therapeutics Inc   63.77 %
Aurinia Pharmaceuticals Inc   56.37 %
Pulmatrix Inc   53.09 %
Novavax inc   51.88 %
Gsk Plc  51.22 %
Q32 Bio Inc   50.33 %
Idexx Laboratories Inc  48.69 %
Theravance Biopharma inc   46.03 %
Elite Pharmaceuticals Inc   45.80 %
Enlivex Therapeutics Ltd  45.75 %
Galmed Pharmaceuticals Ltd   43.72 %
Abeona Therapeutics Inc   42.25 %
Alpha Tau Medical Ltd  42.04 %
Dariohealth Corp   41.31 %
Acadia Pharmaceuticals Inc   39.64 %
Medinotec Inc   37.45 %
Zevra Therapeutics Inc   36.78 %
Oramed Pharmaceuticals Inc  35.86 %
Ptc Therapeutics inc   35.12 %
Mettler toledo International Inc   34.74 %
Newgenivf Group Limited  32.05 %
Eli Lilly And Company  31.62 %
Indivior Pharmaceuticals Inc   31.00 %

Date modified: 2026-07-07T10:26:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.